Use of alpha-toxin for treating and preventing Staphylococcus infections

Details for Australian Patent Application No. 2007259415 (hide)

Owner NABI Biopharmaceuticals

Inventors Fattom, Ali I.; Taylor, Kimberly L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007259415

PCT Pub. Number WO2007/145689

Priority 60/812,598 12.06.06 US; 60/875,363 18.12.06 US

Filing date 27 February 2007

Wipo publication date 21 December 2007

International Classifications

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2007/145689 Priority application(s): WO2007/145689

19 August 2010 Assignment before Grant

  NABI Biopharmaceuticals The application has been assigned to GlaxoSmithKline Biologicals SA 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007259418-Hostile intention assessment system and method

2007259408-Oral DTPA for radionuclide chelation